TagF-like Capsule Polymerase Synthesizing Dimeric Polysaccharides
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current capsule polymerases can only synthesize polysaccharides with either glycosidic or phosphodiester linkages, but not both, and are limited to producing trimeric repeating units, whereas a capsule polymerase capable of synthesizing dimeric repeating units with both linkage types is needed.
Innovation Solution
The development of TagF-like capsule polymerases that combine glycosyltransferase and hexose-/alditol-phosphate transferase activity, featuring a TagF-like domain with either a GT-A or GT-B fold, enabling the synthesis of polysaccharides with dimeric repeating units through both glycosidic and phosphodiester linkages.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional capsule polymerases are used, then polysaccharides with either glycosidic or phosphodiester linkages can be synthesized, but not both linkage types in the same polymer
Solution Approach 1:
The patent combines glycosyltransferase and hexose-/alditol-phosphate transferase activities into a single TagF-like capsule polymerase enzyme. This merging of previously separate enzymatic functions into one multifunctional catalyst enables the synthesis of polysaccharides containing both glycosidic and phosphodiester linkages within the same polymer chain, directly resolving the contradiction between versatility and reliability.
Solution Approach 2:
The TagF-like capsule polymerase exhibits multi-functionality by performing both glycosyltransferase and hexose-/alditol-phosphate transferase activities. This universal enzyme can synthesize diverse linkage types (both glycosidic and phosphodiester bonds) in a single catalytic system, achieving the desired versatility without compromising functional accuracy through the unified enzyme structure.
2Adaptability or versatility
If conventional capsule polymerases are used, then polysaccharides with trimeric repeating units can be synthesized, but not dimeric repeating units
Solution Approach 1:
The TagF-like capsule polymerase merges domain structures (TagF-like domain with GT-A or GT-B fold) to create a unified enzyme capable of synthesizing dimeric repeating units. This structural merging enables precise control over the repeating unit architecture, achieving both the desired versatility in structure type and the manufacturing precision required for accurate dimeric unit formation.
3Adaptability or versatility
If a single polymerase is designed to perform multiple functions, then versatility improves, but enzyme complexity increases
Solution Approach 1:
The patent merges multiple enzymatic functions into the TagF-like capsule polymerase structure, accepting increased structural complexity as the necessary trade-off for achieving the desired functional versatility of synthesizing both linkage types and dimeric repeating units.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the production of polysaccharides with dimeric repeating units using TagF-like capsule polymerases, expanding the capabilities of capsule polymerases and potentially enhancing their application in vaccine development and bacterial capsule synthesis.
Implementation Method 1
The TagF-like capsule polymerase family of the present invention, a new family of polymerases, combines glycosyltransferase and hexose-/alditol-phosphate transferase activity
Implementation Method 2
The TagF-like capsule polymerase family of the present invention, a new family of polymerases, combines glycosyltransferase and hexose-/alditol-phosphate transferase activity
Data Source
AI summary
The present invention relates to a host cell, which comprises under the control of a heterologous promoter a polynucleotide comprising a nucleotide sequence encoding a polypeptide capable of synthesizing a polysaccharide consisting of a dimeric repeating unit as well as to a vaccine composition comprising such host cell. Furthermore, either such host cell or a polypeptide expressed by such host cell is used for the production of a polysaccharide consisting of a dimeric repeating unit which may be used as a glycoconjugate vaccine.


